StonvexLoading…
StonvexStonvexStonvexCore line items from VSTM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 |
|---|---|---|---|---|
Revenue | $10.00M | $2.60M | $2.05M | $88.52M |
Operating Income | $-114.96M | $-72.94M | $-61.41M | $-49.36M |
Net Income | $-130.64M | $-73.81M | $-71.20M | $-67.73M |
EPS (Diluted) | $-3.66 | $-4.57 | $-4.90 | $-0.44 |
Total Assets | $101.54M | $95.05M | $108.66M | $154.35M |
Total Liabilities | $130.43M | $47.66M | $21.10M | $39.08M |
Cash & Equivalents | $88.82M | $74.93M | $21.25M | $67.78M |
Free Cash Flow OCF − CapEx | $-104.80M | Not available | $-53.70M | $-33.54M |
Shares Outstanding | 44.78M | 16.71M | 185.29M | 170.46M |